Cambridge Healthtech Institute’s 7th Annual

Liquid Biopsy & Circulating Tumor Cells

Enabling Precision Oncology for Diagnostic and Drug Development

June 20-21, 2022


Liquid biopsy is a maturing technology for early detection of disease, patient stratification and therapy selection, monitoring response to therapy, and detecting disease recurrence. Cambridge Healthtech Institute’s 7th Annual Liquid Biopsy & Circulating Tumor Cells meeting will explore the latest technologies in detection and molecular characterization of CTCs, cell-free circulating tumor DNA (cfDNA) and circulating extracellular RNA, exosomes and microvesicles, as well as the applications of liquid biopsy in diagnostics and drug development.


Coverage will include, but is not limited to:


  • Technology update in liquid biopsy detection and characterization
  • Cancer screening and early detection
  • Liquid biopsy for minimal residual disease detection
  • Applications of cell-free DNA and RNA as biomarkers in drug development
  • Exosomes and microvesicles as biomarkers
  • Predicting immunotherapy response through circulating immune cells
  • Liquid biopsy for companion diagnostics


If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is December 3, 2021.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:

Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: 760-994-5992



For partnering and sponsorship information, please contact:

Jon Stroup

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5483